- Home
- SNSE vs AQMS Comparison
SNSE vs AQMS Comparison
Compare SNSE & AQMS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- SNSE
- AQMS
- Stock Information
- Founded
- SNSE 2005
- AQMS 2014
- Country
- SNSE United States
- AQMS United States
- Employees
- SNSE N/A
- AQMS N/A
- Industry
- SNSE Biotechnology: Pharmaceutical Preparations
- AQMS Metal Fabrications
- Sector
- SNSE Health Care
- AQMS Industrials
- Exchange
- SNSE Nasdaq
- AQMS Nasdaq
- Market Cap
- SNSE 9.3M
- AQMS 11.1M
- IPO Year
- SNSE 2021
- AQMS 2015
- Fundamental
- Price
- SNSE $0.34
- AQMS $0.76
- Analyst Decision
- SNSE Strong Buy
- AQMS Strong Buy
- Analyst Count
- SNSE 4
- AQMS 3
- Target Price
- SNSE $4.25
- AQMS $21.00
- AVG Volume (30 Days)
- SNSE 150.3K
- AQMS 197.1K
- Earning Date
- SNSE 05-06-2025
- AQMS 08-04-2025
- Dividend Yield
- SNSE N/A
- AQMS N/A
- EPS Growth
- SNSE N/A
- AQMS N/A
- EPS
- SNSE N/A
- AQMS N/A
- Revenue
- SNSE N/A
- AQMS N/A
- Revenue This Year
- SNSE N/A
- AQMS N/A
- Revenue Next Year
- SNSE N/A
- AQMS $550.00
- P/E Ratio
- SNSE N/A
- AQMS N/A
- Revenue Growth
- SNSE N/A
- AQMS N/A
- 52 Week Low
- SNSE $0.25
- AQMS $0.73
- 52 Week High
- SNSE $0.87
- AQMS $8.20
- Technical
- Relative Strength Index (RSI)
- SNSE 50.22
- AQMS 28.96
- Support Level
- SNSE $0.31
- AQMS $0.73
- Resistance Level
- SNSE $0.33
- AQMS $0.95
- Average True Range (ATR)
- SNSE 0.04
- AQMS 0.07
- MACD
- SNSE 0.01
- AQMS 0.01
- Stochastic Oscillator
- SNSE 75.25
- AQMS 8.61
About SNSE Sensei Biotherapeutics Inc.
Sensei Biotherapeutics Inc is an immuno-oncology company focused on the discovery and development of next-generation therapeutics for cancer patients. Its TMAb (Tumor Microenvironment Activated Biologics) platform developing selective therapeutics designed to disable immunosuppressive signals or activate immunostimulatory signals selectively in the tumor microenvironment. The company have four investigational product candidates in various stages of development: SNS-101 (VISTA), SNS-102 (VSIG4 ), SNS-103 (ENTPDase/CD39), SNS-201 (VISTAxCD28).
About AQMS Aqua Metals Inc.
Aqua Metals Inc is engaged in the business of recycling Lead through a novel, proprietary and patent-pending process that it developed and named AquaRefining. The company's breakthrough, AquaRefining, delivers a product, at a higher yield, eliminates toxic waste, reduces permitting, and is less expensive to build than smelting. AquaRefining process will provide for the recycling of Lead acid batteries and the production of a pure grade Lead with a significantly lower cost of production, and with fewer environmental and regulatory issues, than conventional methods of Lead production.